🇺🇸 FDA
Pipeline program

CBS001

CBS001-01

Phase 1 small_molecule terminated

Quick answer

CBS001 for Chronic Inflammatory Disease is a Phase 1 program (small_molecule) at Centessa Pharmaceuticals plc with 1 ClinicalTrials.gov record(s).

Program details

Company
Centessa Pharmaceuticals plc
Indication
Chronic Inflammatory Disease
Phase
Phase 1
Modality
small_molecule
Status
terminated

Clinical trials